Carl Zeiss Meditec AG (0DHC.L)

136,62 +5,19 (+3,95%) Alla chiusura: 06:18PM BST

Carl Zeiss Meditec AG

Goschwitzer Strasse 51-52
Jena 07745
Germany
49 3641 220 115
https://www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

Settore/i: 
Settore: 
Impiegati a tempo pieno: 4.823

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Markus Weber	CEO & Chairman of Management Board	905,4k	N/D	N/D
Mr. Justus Felix Wehmer	CFO & Member of the Management Board	609,4k	N/D	1965
Dr. Christian Munster	Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board	N/D	N/D	1971
Stefanie Spanagel	Chief Operating Officer	N/D	N/D	N/D
Mr. Sebastian Frericks	Director of Investor Relations	N/D	N/D	N/D
Eva-Maria Heine	Chief Human Resources Officer	N/D	N/D	N/D
Mr. Steven C. Schallhorn M.D.	Chief Medical Officer for Global Ophthalmic Devices	N/D	N/D	N/D
Mr. Andrew Chang	Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.	N/D	N/D	N/D
Dr. Euan S. Thomson Ph.D.	President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit	N/D	N/D	1963
Mr. Magnus Reibenspiess	Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Governance aziendale

L'ISS Governance QualityScore di Carl Zeiss Meditec AG al 1 aprile 2024 è 8. I criteri di valutazione fondamentali sono revisione: 4; Consiglio di Amministrazione: 7; diritti degli azionisti: 6; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.